Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2020-06-17 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 17 June 2020, addressed to stock exchanges and a Luxembourg stock exchange, informing them about the schedule of an Analyst / Institutional Investor Meeting on 18 June 2020. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of a meeting schedule, with no financial data, analysis, or report attached. The document length is only 1593 characters, indicating it is a brief notice rather than a detailed report or transcript. Therefore, it fits best under the category of Investor Presentation announcements or meeting schedule notifications. However, since it is only an intimation of the schedule and not the presentation itself, the closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-06-17 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended 31st March, 2020, as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed financial data on transactions, remuneration, investments, and payables related to key management personnel and related parties. The document is not a full financial report like an Annual Report or Interim Report but a specific regulatory disclosure about related party transactions. It is not an announcement or a brief summary but a substantive disclosure with financial figures. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-06-12 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated ....
Regulatory Filings
2020-06-12 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is a formal announcement dated June 10, 2020, addressed to stock exchanges and a Luxembourg stock exchange, indicating compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details Cipla Limited's acquisition of a 21.85% stake in GoApptiv Private Limited, including specifics about the transaction stages, shareholding percentages, consideration type (cash), and background information about the acquired company. The content focuses on the acquisition event and regulatory disclosure requirements rather than financial results, management changes, or other report types. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through acquisition. The document length (6402 characters) and detailed transaction information support this classification with high confidence.
2020-06-10 English
Cipla has signed agreements on 9th June 2020, to acquire shares representing 21.85% stake in GoApptiv Private Limited on a fully diluted basis. The details as required under ....
Regulatory Filings
2020-06-10 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2020-06-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.